Brown Brothers Harriman & Co’s Prestige Consumer Healthcare PBH Stock Holding History

Brown Brothers Harriman & Co’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-94	Closed	-$5.8K	–	1879
2025 Q4	$5.8K	Sell	94 -610	-87%	-$37.3K	﹤0.01%	1468
2025 Q3	$43.9K	Buy	+704	New	+$49K	﹤0.01%	1027
2023 Q4	–	Sell	-25	Closed	-$1.43K	–	1241
2023 Q3	$1.43K	Hold	25	–	–	﹤0.01%	1132
2023 Q2	$1.49K	Sell	25 -14	-36%	-$838	﹤0.01%	1149
2023 Q1	$2.44K	Buy	+39	New	+$2.44K	﹤0.01%	1139
2020 Q2	–	Sell	-116	Closed	-$4K	–	1141
2020 Q1	$4K	Buy	+116	New	+$4.5K	﹤0.01%	835
2019 Q1	–	Sell	-48	Closed	-$1K	–	1078
2018 Q4	$1K	Buy	+48	New	+$1.75K	﹤0.01%	906
2017 Q1	–	Sell	-126	Closed	-$7K	–	856
2016 Q4	$7K	Hold	126	–	–	﹤0.01%	739
2016 Q3	$6K	Hold	126	–	–	﹤0.01%	666
2016 Q2	$7K	Buy	+126	New	+$6.94K	﹤0.01%	678

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Brothers Harriman & Co's PBH Position: Q1 2026 in Review

Brown Brothers Harriman & Co sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 94 shares — an estimated $5.8K sold.

Brown Brothers Harriman & Co first reported a position in PBH in Q2 2016 and held it in 10 quarters. The position peaked at $43.9K in Q3 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

Brown Brothers Harriman & Co reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
Brown Brothers Harriman & Co sold 94 Prestige Consumer Healthcare shares in Q1 2026, an estimated $5.8K.
Brown Brothers Harriman & Co first reported a position in Prestige Consumer Healthcare in Q2 2016 and held it in 10 quarters.
Brown Brothers Harriman & Co's Prestige Consumer Healthcare position peaked at $43.9K in Q3 2025.
355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.